There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 2 M cells/vial*2 |
| Description | B4GALT6 knockout Jurkat cell line lacks B4GALT6 protein, beta-1,4-galactosyltransferase 6, a member of beta4GalT family with diverse glycosylation functions. B4GALT6 knockout in Jurkat cells enables study of glycoconjugate biosynthesis disruption in T-cell leukemia, potentially affecting diverse beta-1,4-galactosyltransferase dependent glycosylation pathways and further elucidating beta4GalT functional complexity in tumor biology. |
| Product Type | KO Cell Lines |
| Species | Human |
| Cell Morphology | Suspension-growing |
| Passage Ratio | 1:3~1:5 |
| Cell Line | Jurkat cell line |
| Primary Disease | T-cell acute lymphoblastic leukemia (T-ALL) |
| Lineage | T Lymphocyte |
| Lineage Subtype | T-cell acute lymphoblastic leukemia (T-ALL) |
| Cell Viability | >90% |
| Sterility Test | The sterility test indicated an absence of microbial growth. |
| Identity Test | STR identification |
| Mycoplasma Test | Negative |
| Virus Test | Negative for HIV, HBV and HCV. |
| Genetic Stability Testing | We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements. |
| Validation | PCR, Sanger Sequencing |
| Culture Medium | FBS & Penicillin/Streptomycin & RPMI |
| Application | Functional assay |
| Size | 2 M cells/vial*2 |
| Product Format | Frozen |
| Shipping | Dry ice |
| Availability Status | Made to order |
| Handling Notes | Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to. |
| Product Disclaimer | This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous. |
| Target | B4GALT6 |
| Full Name | Beta-1,4-galactosyltransferase 6 |
| Alternative Name | beta4GalT-VI |
| Location | 18q12.1 |
| Gene ID | 9331 |
| Summary | Beta-1,4-galactosyltransferase with exclusive specificity for UDP-galactose; transfers galactose in a beta1,4 linkage to various acceptor sugars; involved in glycoconjugate biosynthesis. |